These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21971141)

  • 21. [Two Cases of Liver Metastasis from Pancreatic Cancer with a Complete Response Owing to Chemotherapy].
    Suda H; Omori K; Suematsu Y; Hiratsuka M; Takahashi M; Saito H; Ishibashi Y; Morita A; Wakabayashi K; Ito Y
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2388-90. PubMed ID: 26805373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreatectomy with major arterial resection after neoadjuvant chemoradiotherapy gemcitabine and S-1 and concurrent radiotherapy for locally advanced unresectable pancreatic cancer.
    Amano R; Kimura K; Nakata B; Yamazoe S; Motomura H; Yamamoto A; Tanaka S; Hirakawa K
    Surgery; 2015 Jul; 158(1):191-200. PubMed ID: 25900035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A long-term survival case of pancreatic cancer with hepatic metastasis after pancreaticoduodenectomy successfully treated by s-1 and gemcitabine combination chemotherapy].
    Hoshino H; Takeda Y; Nagano H; Nakamori S; Kobayashi S; Eguchi H; Marubashi S; Tanemura M; Kitagawa T; Umeshita K; Monden M; Doki Y; Mori M
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2419-21. PubMed ID: 20037442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recent important insights into treatment of pancreatic cancer].
    Abe N; Sugiyama M; Atomi Y
    Gan To Kagaku Ryoho; 2005 May; 32(5):617-23. PubMed ID: 15918560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and immunologic evaluation of dendritic cell-based immunotherapy in combination with gemcitabine and/or S-1 in patients with advanced pancreatic carcinoma.
    Kimura Y; Tsukada J; Tomoda T; Takahashi H; Imai K; Shimamura K; Sunamura M; Yonemitsu Y; Shimodaira S; Koido S; Homma S; Okamoto M
    Pancreas; 2012 Mar; 41(2):195-205. PubMed ID: 21792083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gemcitabine plus S-1 for metastatic pancreatic cancer.
    Zhu H; Yi C; Zhao Y; Gou H
    Medicine (Baltimore); 2018 Oct; 97(41):e12836. PubMed ID: 30313120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer.
    Nakachi K; Furuse J; Kinoshita T; Kawashima M; Ishii H; Ikeda M; Mitsunaga S; Shimizu S
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):527-34. PubMed ID: 19967537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival effects of adjuvant gemcitabine plus S-1 chemotherapy on pancreatic carcinoma stratified by preoperative resectability status.
    Murakami Y; Uemura K; Hashimoto Y; Kondo N; Nakagawa N; Takahashi S; Shintakuya R; Sueda T
    J Surg Oncol; 2016 Mar; 113(4):405-12. PubMed ID: 26750513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase II trial of neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy combined with gemcitabine and S-1 for borderline-resectable pancreatic cancer with arterial involvement.
    Nagakawa Y; Hosokawa Y; Nakayama H; Sahara Y; Takishita C; Nakajima T; Hijikata Y; Kasuya K; Katsumata K; Tokuuye K; Tsuchida A
    Cancer Chemother Pharmacol; 2017 May; 79(5):951-957. PubMed ID: 28378027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase 1 study of gemcitabine/nab-paclitaxel/S-1 (GAS) combination neoadjuvant chemotherapy for patients with locally advanced pancreatic adenocarcinoma.
    Kondo N; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakagawa N; Takahashi S; Ohge H; Sueda T
    Cancer Chemother Pharmacol; 2017 Apr; 79(4):775-781. PubMed ID: 28293715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical benefit of full-dose gemcitabine for advanced pancreatic cancer refractory to S-1+gemcitabine].
    Hachisuka H; Takahashi M; Kushima A; Nakamoto T; Takahashi K; Iwamura Y; Wakata M; Nagano K; Nakajima T; Nunomura M; Araki K
    Gan To Kagaku Ryoho; 2013 May; 40(5):639-42. PubMed ID: 23863590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case report of hepatic arterial infusion chemotherapy and RFA for liver metastasis from pancreatic cancer].
    Nakayama A; Tajima H; Kitagawa H; Shoji M; Nakanuma S; Makino I; Hayashi H; Nakagawara H; Miyashita T; Takamura H; Ohta T
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2205-7. PubMed ID: 25731471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early initiation of adjuvant chemotherapy improves survival of patients with pancreatic carcinoma after surgical resection.
    Murakami Y; Uemura K; Sudo T; Hashimoto Y; Kondo N; Nakagawa N; Sasaki H; Sueda T
    Cancer Chemother Pharmacol; 2013 Feb; 71(2):419-29. PubMed ID: 23178955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of effective treatment with S-1/gemcitabine chemotherapy and resection for advanced pancreatic cancer with peritoneal dissemination].
    Koga H; Miyoshi A; Nakamura J; Ide T; Kitahara K; Noshiro H
    Gan To Kagaku Ryoho; 2014 May; 41(5):665-8. PubMed ID: 24917019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is S-1 a potential game changer in adjuvant therapy of pancreatic cancer?
    Chaulagain CP; Rothschild J; Saif MW
    JOP; 2013 Jul; 14(4):329-33. PubMed ID: 23846920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcomes of chemotherapy in patients with undifferentiated carcinoma of the pancreas: a retrospective multicenter cohort study.
    Imaoka H; Ikeda M; Maehara K; Umemoto K; Ozaka M; Kobayashi S; Terashima T; Inoue H; Sakaguchi C; Tsuji K; Shioji K; Okamura K; Kawamoto Y; Suzuki R; Shirakawa H; Nagano H; Ueno M; Morizane C; Furuse J
    BMC Cancer; 2020 Oct; 20(1):946. PubMed ID: 33004032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pancreatic cancer showing complete pathological response to preoperative chemoradiotherapy-a case report].
    Tanizaki K; Hama N; Tomimaru Y; Eguchi H; Akita H; Wada H; Kawamoto K; Kobayashi S; Mori M; Doki Y; Nagano H
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1872-4. PubMed ID: 24393950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gemcitabine plus S-1 combination therapy (GS therapy) for pancreatic cancer patients with high-grade hepatic metastasis].
    Matsumoto T; Takeji S; Asagi A; Kajiwara T; Nishina T; Hori S; Ikeda Y; Nadano S; Iguchi H
    Nihon Shokakibyo Gakkai Zasshi; 2011 Dec; 108(12):2003-9. PubMed ID: 22139487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. S-1 or gemcitabine adjuvant therapy in resected pancreatic cancer: a cost-effectiveness analysis based on the JASPAC-01 trial.
    Liao W; Huang J; Zhu G; Zhou J; Wen F; Zhang P; Zhou K; Wu Q; Wang X; Gou H; Li Q
    Expert Rev Pharmacoecon Outcomes Res; 2020 Feb; 20(1):133-138. PubMed ID: 31597496
    [No Abstract]   [Full Text] [Related]  

  • 40. A single-arm, phase II trial of neoadjuvant gemcitabine and S1 in patients with resectable and borderline resectable pancreatic adenocarcinoma: PREP-01 study.
    Motoi F; Satoi S; Honda G; Wada K; Shinchi H; Matsumoto I; Sho M; Tsuchida A; Unno M;
    J Gastroenterol; 2019 Feb; 54(2):194-203. PubMed ID: 30182219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.